Citigroup’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-45,000
Closed -$358K 5871
2025
Q1
$358K Buy
45,000
+5,100
+13% +$37.3K ﹤0.01% 3856
2024
Q4
$217K Hold
39,900
﹤0.01% 4368
2024
Q3
$288K Sell
39,900
-6,800
-15% -$62.3K ﹤0.01% 4099
2024
Q2
$507K Buy
+46,700
New +$598K ﹤0.01% 3387
2023
Q3
Sell
-20,000
Closed -$940K 5790
2023
Q2
$940K Hold
20,000
﹤0.01% 2891
2023
Q1
$839K Buy
+20,000
New +$860K ﹤0.01% 2688
2022
Q1
Sell
-50,000
Closed -$2.13M 6570
2021
Q4
$2.13M Buy
+50,000
New +$2.09M ﹤0.01% 2575
2021
Q1
Sell
-41,500
Closed -$3.59M 7220
2020
Q4
$3.59M Buy
41,500
+13,600
+49% +$1M ﹤0.01% 2332
2020
Q3
$1.71M Sell
27,900
-11,300
-29% -$573K ﹤0.01% 2792
2020
Q2
$1.63M Buy
39,200
+4,200
+12% +$152K ﹤0.01% 3041
2020
Q1
$1M Sell
35,000
-29,700
-46% -$1.72M ﹤0.01% 3172
2019
Q4
$4.67M Buy
64,700
+34,400
+114% +$4.23M ﹤0.01% 2076
2019
Q3
$4.25M Sell
30,300
-20,300
-40% -$3.4M ﹤0.01% 2083
2019
Q2
$9.26M Sell
50,600
-1,700
-3% -$290K 0.01% 1448
2019
Q1
$8.32M Buy
52,300
+7,600
+17% +$1.1M 0.01% 1397
2018
Q4
$4.28M Sell
44,700
-5,000
-10% -$572K ﹤0.01% 1950
2018
Q3
$7.02M Buy
49,700
+21,400
+76% +$3.3M 0.01% 1547
2018
Q2
$4.43M Sell
28,300
-300
-1% -$47.1K ﹤0.01% 1949
2018
Q1
$4.61M Sell
28,600
-24,200
-46% -$4.11M ﹤0.01% 1843
2017
Q4
$8.7M Buy
52,800
+41,300
+359% +$4M 0.01% 1392
2017
Q3
$716K Sell
11,500
-47,300
-80% -$3.71M ﹤0.01% 3722
2017
Q2
$4.68M Sell
58,800
-6,500
-10% -$470K ﹤0.01% 1746
2017
Q1
$4.64M Buy
65,300
+55,800
+587% +$3.27M ﹤0.01% 1729
2016
Q4
$485K Buy
+9,500
New +$448K ﹤0.01% 4409

Other funds holding SAGE